In a transgenic mouse model of Alzheimer's disease, sleeve gastrectomy performed early in life reduced fat mass, improved insulin sensitivity, and lowered cortical amyloid burden and glial activation — effects that occurred independently of reduced caloric intake. Under continued Western-diet feeding, the procedure also reduced frailty and restored spatial memory, implicating a brain insulin signaling–autophagy axis as the mechanistic link between peripheral metabolic correction and neurodegenerative pathology.
Key Points
- Sleeve gastrectomy lowered cortical amyloid plaque burden in AD mice
- Benefits occurred independent of food intake or caloric restriction
- Spatial memory and frailty improved despite continued Western-diet feeding
Longevity Analysis
Metabolic dysfunction in the periphery writes itself into the brain, and correcting insulin handling at the level of the gut altered amyloid deposition and glial activation in cortex — a reminder that neurodegeneration is rarely a purely neurological problem. The finding that benefit persisted under ongoing Western-diet exposure, and did not depend on eating less, separates the metabolic signal from the simple arithmetic of calories, and points toward insulin signaling and cellular clearance machinery as the operative targets. For clinical translation, the more generalizable lesson concerns timing: the intervention was applied early, before pathology consolidated, which is where metabolic correction appears to carry the most leverage over cognitive trajectory.
Original published by Wiley Aging Cell, by Reji Babygirija, Julia A. Illiano, Michelle M. Sonsalla, Grace Zhu, Christopher Retter Jabbarpour, Twinkle Mathew, Tristan Molkentin, Meredith Peterson, Carolyn Winder, Advaith Ravi Krishnan Nair, Fan Xiao, Justin M. Wolter, Dudley W. Lamming, David A. Harris .